NDC 50090-8161-00 - Pravastatin sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-8161
- Requested NDC
- 50090-8161-00
- Package NDCs from labels
- 50090-8161-1, 50090-8161-0, 50090-8161-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pravastatin sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-10-23 | Human Prescription Drug Label |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Havix Group Inc d-b-a Aavis Pharmaceuticals | 222b90fd-f070-4fa8-8f8b-720133cb2b0a | 2026-11-06 | 3M8608UQ61 | |
| Pravastatin sodium | PRAVASTATIN SODIUM | A-S Medication Solutions | be592e98-8a17-4c18-99b8-0f3a67000e2d | 2026-10-23 | Warnings, Adverse reactions | ANDA076056 50090-8161-1 50090-8161-0 50090-8161 50090816100 904475 6225e608-db94-43e3-920e-ee43b508d700 be592e98-8a17-4c18-99b8-0f3a67000e2d 3M8608UQ61 |
| Pravastatin sodium | PRAVASTATIN SODIUM | Northwind Health Company, LLC | 47207487-0c6d-8da3-e063-6294a90a8aee | 2026-10-16 | Warnings, Adverse reactions | 3M8608UQ61 |
| Pravastatin sodium | PRAVASTATIN SODIUM | Northwind Health Company, LLC | 40aa2d36-57ce-1f48-e063-6294a90affef | 2026-10-16 | Warnings, Adverse reactions | 3M8608UQ61 |
| Pravastatin Sodium | PRAVASTATIN SODIUM | NorthStar RxLLC | ce15ad07-3286-478f-9f30-1db6a45ed402 | 2026-09-28 | Warnings, Adverse reactions | 904458 904467 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | CIPLA USA INC. | 678dfe58-3200-4c3d-9718-365aa47d070f | 2026-09-24 | Warnings, Adverse reactions | 904458 904467 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | REMEDYREPACK INC. | 76e5fdf8-bd03-4cd5-9361-e61678cb3de9 | 2026-09-22 | Warnings, Adverse reactions | 904458 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Major Pharmaceuticals | 1d5bce9c-a788-4c52-a69e-c53174b8d061 | 2026-09-17 | Warnings, Adverse reactions | 904458 904467 904475 3M8608UQ61 |
| Pravastatin sodium | PRAVASTATIN SODIUM | Aurobindo Pharma Limited | 42ccbca7-fa52-4df9-8f1a-ea7da7312883 | 2026-09-10 | Warnings, Adverse reactions | 3M8608UQ61 |
| Pravastatin sodium | PRAVASTATIN SODIUM | REMEDYREPACK INC. | 6cef5e92-26b7-435c-878f-72a05a624560 | 2026-09-10 | Warnings, Adverse reactions | ANDA076056 904467 3M8608UQ61 |
| Pravastatin sodium | PRAVASTATIN SODIUM | REMEDYREPACK INC. | fa152ce7-6c07-4aaf-9374-932ce81d0cf9 | 2026-09-04 | Warnings, Adverse reactions | ANDA076056 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | REMEDYREPACK INC. | 5ecd9fd1-7662-412d-99c5-13c77188748c | 2026-08-21 | Warnings, Adverse reactions | 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | REMEDYREPACK INC. | e4dbaa72-7b3e-4aef-983b-90efb2b343cd | 2026-08-21 | Warnings, Adverse reactions | 904467 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Preferred Pharmaceuticals Inc. | 6d42bd30-1f09-49f4-9ec8-31366df1b4b4 | 2026-08-17 | Warnings, Adverse reactions | 904467 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Preferred Pharmaceuticals Inc. | 46cdd32d-a022-4acf-ba2b-10e7877d56c6 | 2026-08-17 | Warnings, Adverse reactions | 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Preferred Pharmaceuticals Inc.. | ebd794ba-90c3-4d81-9c45-4aa9d9454359 | 2026-08-17 | Warnings, Adverse reactions | 3M8608UQ61 |
| Pravastatin Sodium | PRAVASTATIN SODIUM | Preferred Pharmaceuticals Inc. | 095ac6fd-fdfb-4207-b15d-8e93bee378c3 | 2026-08-17 | Warnings, Adverse reactions | 904458 904467 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Cardinal Health 107, LLC | 3e218ad6-5b47-4cca-81be-ebaea5795964 | 2026-08-13 | Warnings, Adverse reactions | 904458 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Quallent | e9c188f7-cd6f-afac-b493-36552d86589e | 2026-08-03 | Warnings, Adverse reactions | 904467 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Apotex Corp. | dcf45e4f-b46e-6fbb-b67a-2ff619ab1780 | 2026-07-31 | Warnings, Adverse reactions | 904458 904467 904475 3M8608UQ61 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.